C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge

Area of Science:

• Virology
• Pharmacology
• Primatology

Background:

• Vaginal microbicides are crucial for preventing human immunodeficiency virus (HIV) transmission in women.
• Developing safe and effective microbicides remains a public health priority.

Purpose of the Study:

• To evaluate the safety and microbicidal efficacy of the amphipathic peptide C5A.
• To assess C5A's protective potential against simian-human immunodeficiency virus (SHIV) in a rhesus macaque model.

Main Methods:

• Vaginal application of C5A in rhesus macaques.
• Challenge with simian-human immunodeficiency virus (SHIV-162P3).
• Monitoring for safety, lesions, and inflammation.

Main Results:

• Vaginal C5A application protected 89% of macaques from SHIV challenge.
• Repeated C5A treatments showed no signs of lesions or inflammation.
• C5A demonstrated noncellular cytotoxic activity.

Conclusions:

• C5A is a safe and effective vaginal microbicide candidate.
• Its unique mechanism of action makes it an attractive option for HIV prevention.
• Further development of C5A is warranted for potential human use.